Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trajan Group HoldingsASX:TRJ -10.34%38 Days Payable is 44.42 as of Dec. 2025, which is 16% above its 10-year median of 38.43. GuruFocus rates ASX:TRJ with a GF Score™ of 38/100 and a GF Value™ of A$1.11 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Trajan Group Holdings ranks worse than 63.44% on this metric.
The historical rank and industry rank for Trajan Group Holdings's Days Payable or its related term are showing as below:
ASX:TRJ'
s Days Payable Range Over the Past 10 Years
Min: 34.84 Med: 38.43 Max: 53.89
Current: 53.89
During the past 5 years, Trajan Group Holdings's highest Days Payable was 53.89. The lowest was 34.84. And the median was 38.43.
ASX:TRJ's Days Payable is ranked worse than 63.44% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs ASX:TRJ: 53.89
Trajan Group Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for Trajan Group Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:TRJ vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Trajan Group Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trajan Group Holdings Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Trajan Group Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Trajan Group Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Trajan Group Holdings's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trajan Group Holdings (ASX:TRJ) has a Days Payable of 44.42 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Trajan Group Holdings and its competitors. This is 16% above median its historical median of 38.43. Over the past decade, Trajan Group Holdings' Days Payable has ranged from 34.84 to 53.89. According to the industry distribution chart, Trajan Group Holdings ranks #505 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 63.4%.
Is Trajan Group Holdings' Days Payable too high?
Trajan Group Holdings' current Days Payable of 44.42 is 16% above median its 10-year median of 38.43. Over the past 10 years, this metric has ranged from a low of 34.84 to a high of 53.89. The Medical Devices & Instruments industry median Days Payable is 67.97. Trajan Group Holdings' value of 44.42 is 34.6% below this industry median. Based on the distribution chart, Trajan Group Holdings ranks #505 out of 796 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Trajan Group Holdings has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trajan Group Holdings' Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Trajan Group Holdings ranks #505 out of 796 companies for Days Payable. This places Trajan Group Holdings in the lower half of its industry. The industry median Days Payable is 67.97. Trajan Group Holdings' value of 44.42 is 34.6% below this benchmark. Historically, Trajan Group Holdings' own Days Payable has ranged from 34.84 to 53.89 over the past decade. While the company's 10-year median is 38.43 vs. the industry median of 67.97, Trajan Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trajan Group Holdings's current Days Payable of 44.42 is 34.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Trajan Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trajan Group Holdings's current Days Payable is 44.42, which is 16% above median its own 10-year median of 38.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trajan Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Trajan Group Holdings (ASX:TRJ) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.11, compared to a current price of A$0.26 — trading 76.6% below its estimated fair value. The current Days Payable is 44.42, which is 16% above median its 10-year median of 38.43 and 34.6% below the Medical Devices & Instruments industry median of 67.97. Trajan Group Holdings' overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Trajan Group Holdings (ASX:TRJ), the current Days Payable is 44.42 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trajan Group Holdings (ASX:TRJ) Overvalued in 2026?
Based on GuruFocus' analysis, Trajan Group Holdings stock appears to be undervalued.
The current stock price of A$0.26 is trading 76.6% below its estimated GF Value™ of A$1.11.
GuruFocus considers Trajan Group Holdings to be Possible Value Trap.
Key valuation signals for ASX:TRJ:
Days Payable: 44.42 (16% above median its 10-year median of 38.43)
GF Value™: A$1.11 vs. price of A$0.26 (76.6% below fair value)
Industry Position: 34.6% below the Medical Devices & Instruments median (#505 of 796)
No single metric tells the full story. See the ASX:TRJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental samples. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and consumables, which include parts, supplies, components, and consumable products worldwide. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).
38GF Score
Get the complete analysis for ASX:TRJ
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:TRJ has been successfully added to your 
